Insider Selling: MannKind VP Unloads 17,902 Shares of Stock (MNKD)

Share on StockTwits

MannKind (NASDAQ:MNKD) VP Diane Palumbo sold 17,902 shares of the stock on the open market in a transaction dated Monday, June 16th. The shares were sold at an average price of $10.59, for a total value of $189,582.18. Following the sale, the vice president now directly owns 140,956 shares in the company, valued at approximately $1,492,724. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

MNKD has been the subject of a number of recent research reports. Analysts at RBC Capital initiated coverage on shares of MannKind in a research note on Thursday, June 12th. They set an “outperform” rating and a $16.00 price target on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of MannKind in a research note on Wednesday, May 14th. They now have a $7.00 price target on the stock. Finally, analysts at Piper Jaffray upgraded shares of MannKind from an “underweight” rating to a “neutral” rating in a research note on Wednesday, May 14th. They now have a $6.50 price target on the stock, up previously from $2.00. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $8.79.

MannKind (NASDAQ:MNKD) traded down 1.23% during mid-day trading on Wednesday, hitting $10.47. 3,068,816 shares of the company’s stock traded hands. MannKind has a one year low of $3.80 and a one year high of $11.11. The stock’s 50-day moving average is $8.1 and its 200-day moving average is $6.32. The company’s market cap is $3.957 billion.

MannKind (NASDAQ:MNKD) last issued its quarterly earnings data on Monday, May 12th. The company reported ($0.14) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.13) by $0.01. During the same quarter last year, the company posted ($0.15) earnings per share. On average, analysts predict that MannKind will post $-0.40 earnings per share for the current fiscal year.

MannKind Corporation (NASDAQ:MNKD) is a development-stage biopharmaceutical company.

Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Marketo Given Consensus Recommendation of “Buy” by Analysts
Marketo Given Consensus Recommendation of “Buy” by Analysts
Polycom Given Consensus Rating of “Buy” by Brokerages
Polycom Given Consensus Rating of “Buy” by Brokerages
BT Group plc Given Consensus Rating of “Buy” by Analysts
BT Group plc Given Consensus Rating of “Buy” by Analysts
Pepco Holdings Receives Average Rating of “Hold” from Analysts
Pepco Holdings Receives Average Rating of “Hold” from Analysts
GenMark Diagnostics Sees Large Growth in Short Interest
GenMark Diagnostics Sees Large Growth in Short Interest
Meredith Corp. Given Average Recommendation of “Hold” by Brokerages
Meredith Corp. Given Average Recommendation of “Hold” by Brokerages


Leave a Reply

 
© 2006-2014 Mideast Time.